Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217795 · ClinicalTrials.gov registry record · NA
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
A NA study of PTSD and Alcohol Use Disorder (AUD), sponsored by University of Rhode Island.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07217795: Recruiting NA study of PTSD and Alcohol Use Disorder (AUD), sponsored by University of Rhode Island.
NCT07217795 is a NA study of PTSD and Alcohol Use Disorder (AUD) that is actively recruiting participants, run by University of Rhode Island. The registered enrollment target is 80 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217795, a NA study of PTSD and Alcohol Use Disorder (AUD), is actively recruiting participants, sponsored by University of Rhode Island.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming. Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
Primary Outcome
Posttraumatic Stress Disorder (PTSD) will be assessed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), a clinician-administered interview that evaluates Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) PTSD criteria. It provides both a total severity score (0-80) and a dichotomous diagnosis (present/absent). Units of Measure: Total score (0-80); diagnosis status (yes/no)
Conditions Studied
Interventions
- BEHAVIORAL CBT + expressive writing
- BEHAVIORAL Wait-List Control
Study Locations (1)
Rhode Island
- University of Rhode Island - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-11-30 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT07217795 shows while recruiting
NCT07217795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which CBT + expressive writing is the first listed.
NCT07217795 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07217795 about?
NCT07217795 is a clinical study titled "Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building". This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirm...
What is the current status of trial NCT07217795?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-11-30. Estimated completion is 2028-09.
What conditions does trial NCT07217795 study?
This clinical trial studies the following conditions: PTSD, Alcohol Use Disorder (AUD).
What interventions are being tested in trial NCT07217795?
The interventions under investigation include: CBT + expressive writing (BEHAVIORAL), Wait-List Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT07217795?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217795 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07217795's enrollment target sits among peer trials
80 73rd of 154 higher than 79 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI